These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 8913919)

  • 41. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.
    Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE
    J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute rejection of hepatic allografts from HLA-DR13 (Allele DRB1(*)1301)-positive donors.
    Oertel M; Berr F; Schröder S; Schwarz R; Tannapfel A; Wenzke M; Lamesch P; Hauss J; Kohlhaw K
    Liver Transpl; 2000 Nov; 6(6):728-33. PubMed ID: 11084059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplants.
    Ratliff NB; McMahon JT
    J Heart Lung Transplant; 1995; 14(2):338-45. PubMed ID: 7779854
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum cytokine levels in heart allograft recipients: correlation with findings on endomyocardial biopsy.
    Jordan SC; Czer L; Toyoda M; Galfayan K; Doan D; Fishbein M; Blanche C; Trento A
    J Heart Lung Transplant; 1993; 12(2):333-7. PubMed ID: 8476907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C4d deposition in cardiac allografts correlates with alloantibody.
    Smith RN; Brousaides N; Grazette L; Saidman S; Semigran M; Disalvo T; Madsen J; Dec GW; Perez-Atayde AR; Collins AB
    J Heart Lung Transplant; 2005 Sep; 24(9):1202-10. PubMed ID: 16143234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histologic and molecular diagnosis of myocardial human cytomegalovirus infection after heart transplantation.
    Pucci A; Ghisetti V; Donegani E; Barbui A; David E; Fortunato M; Papandrea C; Pansini S; Zattera G; di Summa M
    J Heart Lung Transplant; 1994; 13(6):1072-80. PubMed ID: 7865514
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serologic allogeneic chimerism.
    McDonald JC; Adamashvili I; Zibari GB; Aultman DF; Mancini MC; McMillan RW; Gelder FB
    Transplantation; 1997 Sep; 64(6):865-71. PubMed ID: 9326412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of acute or chronic rejection on myocardial collagen density in serial endomyocardial biopsy specimens from cardiac allografts.
    Fornes P; Heudes D; Simon D; Guillemain R; Amrein C; Bruneval P
    J Heart Lung Transplant; 1996 Aug; 15(8):796-803. PubMed ID: 8878762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of risk factors for acute allograft rejection after heart transplantation.
    Carrier M; Russell DH; Cork RC; Wild J; Emery RW; Copeland JG
    J Heart Transplant; 1990; 9(4):372-5. PubMed ID: 2398431
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soluble HLA class I in epithelial lining fluid of lung transplants: associations with graft outcome.
    DeVito-Haynes LD; Jankowska-Gan E; Heisey DM; Cornwell RD; Meyer KC; Love RB; Burlingham WJ
    Hum Immunol; 1997 Feb; 52(2):95-108. PubMed ID: 9077558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic validity of hepatocyte growth factor as marker for rejection in the follow-up of patients after heart transplantation.
    Zwirska-Korczala K; Zakliczyński M; Berdowska A; Zembala M; Jochem J; Gajewska K
    J Heart Lung Transplant; 2005 Apr; 24(4):411-5. PubMed ID: 15797741
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytoimmunologic monitoring as an adjunct in monitoring rejection after heart transplantation: results of a 6-year follow-up in heart transplant recipients.
    Wijngaard PL; Doornewaard H; van der Meulen A; Plomp S; Gmelig Meyling FH; de Jonge N; Schuurman HJ
    J Heart Lung Transplant; 1994; 13(5):869-75. PubMed ID: 7803429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
    Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
    J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of myocardial cell injury in acute cellular rejection versus acute vascular rejection in cyclosporine-treated heart transplants.
    Hook S; Caple JF; McMahon JT; Myles JL; Ratliff NB
    J Heart Lung Transplant; 1995; 14(2):351-8. PubMed ID: 7779856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum myoglobin does not predict cardiac allograft rejection.
    Gash AK; Kayne FJ; Morley D; Fitzpatrick JM; Alpern JB; Brozena SC
    J Heart Lung Transplant; 1994; 13(3):451-4. PubMed ID: 8061022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.
    Jordan SC; Vo A; Bunnapradist S; Toyoda M; Peng A; Puliyanda D; Kamil E; Tyan D
    Transplantation; 2003 Aug; 76(4):631-6. PubMed ID: 12973100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
    el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
    J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myeloperoxidase as serum marker for detection of CMV infections and rejections in patients after liver or heart transplantation.
    Zelzer S; Stiegler P; Kapitan M; Schaffellner S; Schweiger M; Stettin M; Stojakovic T; Truschnig-Wilders M; Tscheliessnigg KH; Khoschsorur G
    Transpl Immunol; 2009 Jan; 20(3):121-6. PubMed ID: 18930821
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human leukocyte antigen sensitization in ventricular assist device recipients: a lesser risk with the DeBakey axial pump.
    Grinda JM; Bricourt MO; Amrein C; Salvi S; Guillemain R; Francois A; Guibourt P; Deloche A; Fabiani JN
    Ann Thorac Surg; 2005 Sep; 80(3):945-8. PubMed ID: 16122460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.